Novel approaches to clinical trial design in cancer neuroscience.

The emerging field of cancer neuroscience has revealed profound bidirectional interactions between the nervous system and cancer cells, identifying novel therapeutic vulnerabilities across diverse malignancies. Master protocols and window-of-opportunity trials provide platforms to rapidly validate mechanisms while addressing patient-centered outcomes.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 This review examines the unique challenges and strategies for translating these insights into effective therapies.
• 2 We propose innovative approaches to overcome these barriers through drug repurposing, enhanced biomarker development, and optimized trial designs.
• 3 Repurposing neuroactive drugs with established safety profiles offers an accelerated path to clinical impact, particularly for targeting glutamatergic, adrenergic, and neurotrophic signaling pathways.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: